Similar Articles
2151 Treatment of hepatocellular carcinoma accompanied by portal vein tumor thrombus
2152 New multi protein patterns differentiate liver fibrosis stages and hepatocellular carcinoma in chronic hepatitis C serum samples
2153 Antitumor activity of an hTERT promoter-regulated tumor-selective oncolytic adenovirus in human hepatocellular carcinoma
2154 Hepatocellular carcinoma prevention: A worldwide emergence between the opulence of developed countries and the economic constraints of developing nations
2155 Role of immunosuppression and tumor differentiation in predicting recurrence after liver transplantation for hepatocellular carcinoma: A multicenter study of 412 patients
2156 Efficacy and safety of thalidomide in patients with hepatocellular carcinoma
2157 Milan criteria are useful predictors for favorable outcomes in hepatocellular carcinoma patients undergoing liver transplantation after transarterial chemoembolization
2158 Precore/basal core promoter mutants and hepatitis B viral DNA levels as predictors for liver deaths and hepatocellular carcinoma
2159 Chemokine expression in hepatocellular carcinoma versus colorectal liver metastases
2160 Hepatocellular carcinoma metastasizing to the skull base involving multiple cranial nerves
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA